The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 16th 2025
Aficamten, a cardiac myosin inhibitor, gains FDA approval, offering hope for improved cardiovascular health in patients with obstructive hypertrophic cardiomyopathy.
US Chamber's Josten to Give NACDS Annual Political Flair
February 23rd 2015Bruce Josten, executive vice president for Government Affairs for the US Chamber of Commerce, will serve as the keynote speaker for the NACDS Political Action Committee breakfast during the 2015 NACDS Annual Meeting.
Read More